trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['biomarker', 't-dxd']
her2 expression is (not quite) a pan-tumour biomarker for t-dxd! #asco23 
Medical oncologist | Cancer researcher | Somatic cancer genetics | Treatment Biomarkers | Rare Cancers | Melanoma and Skin